Search

everythinglearnresearchcommunity

for

Search:↓

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Fetal wound healing changes with development, affecting inflammation and collagen, which may influence scarring.

Lower SHBG levels may increase the risk of PCOS.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced human skin models improve drug development and could replace animal testing.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The new method improves skin cancer detection in imbalanced datasets.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Eclipta prostrata has many traditional uses and health benefits, but more research is needed to understand how it works and ensure it's safe.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.